Arlene S. Bierman, MD, MS
Agency for Healthcare Research and Quality
Director, Center for Evidence and Practice Improvement
Arlene S. Bierman, M.D., M.S., is director of AHRQ’s Center for Evidence and Practice Improvement which consists of five divisions the Evidence-Based Practice Center Program; the U.S. Preventive Services Task Force Program; the Division of Decision Science and Patient Engagement; the Division of Health Information Technology and the Division of Practice Improvement and the National Center for Excellence in Primary Care Research. Dr. Bierman is a general internist, geriatrician and health services researcher whose work has focused on improving access, quality and outcomes of health care for older adults with chronic illness in disadvantaged populations. Dr. Bierman has also developed strategies for using performance measurement as a tool for knowledge translation, as well as conducted research to increase policymakers’ uptake of evidence. As tenured professor she held appointments Health Policy, Evaluation, and Management; Public Health; and Medicine; and Nursing at the University of Toronto, where she was the inaugural holder of the Ontario Women's Health Council Chair in Women's Health and a senior scientist in the Li Ka Shing Knowledge Institute at St. Michael's Hospital. She was also principal investigator for the Project for an Ontario Women’s Health Evidence-Based Report Card (POWER) study, which provided actionable data to help policymakers and health care providers improve health and reduce health inequities in Ontario. Dr. Bierman has served on many advisory committees including the Geriatric Measurement Advisory Panel of the National Committee for Quality Assurance, the boards of Health Quality Ontario, and the National Center of Excellence National Initiative for Care of the Elderly (NICE). She received her MD degree from the University of North Carolina School of Medicine in Chapel Hill where she was a Morehead Fellow. She completed fellowships in Outcomes Research at Dartmouth Medical School, and Community and Preventive Medicine at the Mount Sinai School of Medicine .
Jeffrey Johnson, PhD
University of Alberta
Dr. Johnson is a pharmacist and health outcomes researcher. He received a B.S.P. with Distinction in 1988 and a M.Sc. in clinical pharmacy/ pharmacoepidemiology in 1994, both from the University of Saskatchewan. Dr. Johnson received his Ph.D. in Pharmaceutical Sciences from The University of Arizona in 1996, majoring in pharmaceutical economics.
Dr. Johnson is a Professor in the School of Public Health Sciences at the University of Alberta. He previously held a Canada Research Chair in Diabetes Health Outcomes and a Senior Health Scholar Award with Alberta Innovates-Health Solutions. He chairs the Alliance for Canadian Health Outcomes Research in Diabetes (ACHORD), which has an overall aim of improving the quality and efficiency of care for diabetes. Dr. Johnson is Co-Director of Alberta’s PROMs and EQ-5D Research and Support Unit (APERSU), in partnership with the EuroQol Research Foundation, Alberta Health Services (AHS), and Health Quality Council of Alberta (HQCA).
Rosalie Viney, PhD
University of Technology, Sydney
Professor of Health Economics, Director CHERE
Centre for Health Economics Research and Evaluation
Rosalie Viney is Professor of Health Economics and Director of the Centre for Health Economics Research and Evaluation at the University of Technology Sydney. She has extensive experience in health economics, health services and health policy research. Her research interests include health technology assessment and priority setting, measurement and valuation of quality of life and health outcomes, consumer preferences for health and health care, evaluation of health policy, and the impact of funding arrangements on utilisation and outcomes of health care. Rosalie has undertaken a broad range of commissioned projects for State/Territory Health authorities, and for the Australian Government Department of Health. She is the program leader for the Cancer Australia funded national technical service providing health economics expertise and capacity building to national Cancer Clinical Trials Groups. Rosalie has also had longstanding involvement in the fields of health economics and health services research in Australia, through the Australian Health Economics Society and the Health Services Research Association of Australia and New Zealand. Rosalie is a member of the NHMRC Research Committee. She is also a member of the Pharmaceutical Benefits Advisory Committee (PBAC) and Chair its Economics Sub-Committee.
David GT Whitehurst, PhD
Simon Fraser University
Dr. David Whitehurst is an economist who has specialized in the areas of health and health care throughout his career. His primary research interests focus on the concepts of health state description and valuation, comparability of alternative measurement instruments, individuals’ capacity to adapt to living with health conditions, and the application of economic evaluation techniques alongside intervention studies. Clinical contexts of Dr. Whitehurst’s current work include spinal cord injury, aphasia, older adults and frail seniors.